MeiraGTx Holdings plc (MGTX) stock
MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)
Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –
MeiraGTx market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
MeiraGTx's market cap was $911.74M on Nov 11, 2026, against $667.98M a year earlier. Over the last 5 years it ranged from $250.63M to $1.30B, with a median of $418.37M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $911.74M | +42.5% |
| 2025 | Dec 31, 2025 | $639.81M | +35.2% |
| 2024 | Dec 31, 2024 | $473.17M | +13.1% |
| 2023 | Dec 29, 2023 | $418.37M | +43.5% |
| 2022 | Dec 30, 2022 | $291.51M | -72.3% |
| 2021 | Dec 31, 2021 | $1.05B | +80.9% |
| 2020 | Dec 31, 2020 | $581.56M | -20.6% |
| 2019 | Dec 31, 2019 | $732.17M | +179.4% |
| 2018 | Dec 31, 2018 | $262.06M | – |
See a number that looks wrong?